Abstract
In this contribution it is argued that success and failure of biobanks, defined as their capacity to produce value, depends on establishing a system of governance, a mode of ordering that reflects a strategy for pattering a network of interaction that unfolds along a number of different fields, the scientific/technological field, the medical/health field, the industrial-economic field, the legal-ethical and the socio-political field. Presenting a model for the governance, biobanks are described as a network-structure that is not only a research network but a more extensive network that operates through a variety of nodes in different fields from finance to society and bioethical discourse. Bringing order and stability into such a relatively open and not always well-defined network is the key challenge for today ’s governance of biobanks. The more ambitious a biobank project is with respect to its envisioned value with respect to research, health and industrial application, the more essential is a balanced management of the multiplicity of the potentially involved factors determining success and failure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Berg K (2001). DNA sampling and banking in clinical genetics and genetic research. New Genet Soc 20: 59-68
Biobank UK (2007). Protocol for a large-scale prospective Epidemological Resource. Protocol No: UKBB-PROT-09-06 Adswood
Björkman B, Hansson SO (2006). Bodily rights and property rights. J Med Eth 32: 209-214
Bouchie A (2004). Coming soon: a global grid for cancer research. Nat Biotechnol 22, 1071-1073
Brown, N., and A. Webster. 2004. New Medical Technologies and Society Cambridge: Polity Press
Cambon-Thomsen A (2003). Assessing the impact of biobanks. Nat Genet 34: 25-26
Cambon-Thomsen A., Ducournau P, Gourraud PA, Pontille D (2003). Biobanks for genomics and genomics for biobanks. Comp Functl Genom 4, 628-634
Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM (2007). Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J 30, 373-382
Corrigan O, Petersen A (2008). UK Biobank: bioethics as a technology of governance. In: Gottweis H, Petersen A (eds) Biobanks: Governance in comparative perspective. Routledge, Abingdon: 143-158
Cutter M, Wilson S, Chadwick (2004). Balancing powers: examining models of biobank governance. J Int Biotechnol Law 1: 187-192
Eensaar R (2008). Estonia: ups and downs of a biobank project. In: Gottweis H, Petersen A (eds) Biobanks: Governance in comparative perspective. Routledge, Abingdon: 56-70
Eiseman E, Bloom G, Brower J, Clancy N, Olmsted SS (2003). Human Tissue Repositories. Best Practice for the Genomic and Proteomic Era. Santa Monica: RAND Corporation
Elger BS, Caplan AL (2006). Consent and anonymization in research involving biobanks: Differing terms and norms present serious barriers to an international framework EMBO Reports 7: 661-666
Everett M (2004). Can You Keep a Genetic Secret? The Genetic Privacy Movement. J Genet Counsel 13: 273-291
Gottweis H (2008). Participation and the new governance of life. BioSocieties 3: 265-285
Gottweis H, Petersen A (2008) (eds). Biobanks: Governance in comparative perspective. Routledge, Abingdon
Hagen HE, Carlstedt-Duke J (2004). Building global networks for human diseases: genes and populations. Nat Med 10: 665-667
Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G (2006). Should donors be allowed to give broad consent to future biobank research? Lancet Oncol 7: 266-269
Hirtzlin I, Dubreuil C, Preaubert N, Duchier J, Jansen B, Simon J, Lobato de Faria P, Perez- Lezaun A, Visser B, Williams GD, Cambon-Thomsen A (2003). An empirical survey on biobanking of human genetic material and data in six EU countries. Eur J Hum Genet 11: 475-488
Kaiser J (2002). Population Databases Boom From Iceland to the U.S. Science 298: 1158-1161
Knoppers BM, Chadwick R (2005). Human Genetic Research: Emerging Trends in Ethics. Nat Rev Genet 6: 75-79
Law J (1994). Organizing Modernity. Blackwell, Oxford
Lowrance WW, Collins FS 2007. ETHICS: Identifiability. Genomic Res 317: 600-602
Lunshof J, Chadwick R, Church G (2008). Hippocrates revisited? Old ideals and new realities. Genomic Med 2: 1-3
Lunshof JE, Chadwick R, Vorhaus DB, Church GM (2008). From genetic privacy to open consent. Nat Rev Genet 9: 406-411
Mayrhofer M (2008) Patient organizations as the (un)usual suspects. In: Gottweis H, Petersen A (eds) Biobanks: Governance in comparative perspective. Routledge, Abingdon: 71-87
Muilu J, Peltonen L, Litton JE (2007). The federated database – a basis for biobank-based postgenome studies, integrating phenome and genome data from 600[thinsp]000 twin pairs in Europe. Eur J Hum Genet 15: 718-723
Palsson G (2008). The rise and fall of a biobank: the case of Iceland. In: Gottweis H, Petersen A (eds) Biobanks: Governance in comparative perspective. Routledge, Abingdon: 41-55
Palsson G, Harðardottir KE (2002). For Whom the Cell Tolls: Debates about Biomedicine. Curr Anthropol 43: 271-301
Pálsson G, Harðardóttir KE , Barker JH, Finkler K, Gross M, Helmreich S, Hirsch E, Hornborg A, Metspalu A, Morgan LM, Nelkin D, Proctor RN, Sharp LA, Simpson B, (2002). For Whom the Cell Tolls. Curr Anthropol 43: 271-301
Porteri C, Borry P (2008). A proposal for a model of informed consent for the collection, storage and use of biological materials for research purposes. Pat Educ Couns P 71: 136-142
Reischl J, Schröder M, Luttenberger N, Petrov D, Schümann B, Ternes R, Ternes SS (2006). Pharmacogenetic research and data protection - challenges and solutions. Pharmacogen J 6: 225-233
Shickle D (2006). The consent problem within DNA biobanks. Stud Hist Phil Bio Biomed Sci Part C 37: 503-519
Stark K, Eder J, Zatloukal K (2007). Achieving k-anonymity in DataMarts used for gene expressions exploitation. J Integr Bioinf 4 (Special Issue), http://journal.imbio.de/index.php? paper_id=58
Triendl R, Gottweis H (2008). Governance by stealth: large-scale pharmacogenomics and biobanking in Japan. In: Gottweis H, Petersen A (eds) Biobanks: Governance in comparative perspective. Routledge, Abingdon: 123-139
Tupasela A (2006). Locating tissue collections in tissue economiesderiving value from biomedical research. New Genet Soc 25:33-49
Waldby C (2002). Stem Cells, Tissue Cultures and the Production of Biovalue. Health 6: 305-323
Waldby C, Mitchell R (2006). Tissue economies. Blood, organs, and cell lines in late capitalism. Duke University Press, Durham / London
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Gottweis, H. (2012). Biobanks: Success or Failure?. In: Dabrock, P., Taupitz, J., Ried, J. (eds) Trust in Biobanking. Veröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78845-4_13
Download citation
DOI: https://doi.org/10.1007/978-3-540-78845-4_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78844-7
Online ISBN: 978-3-540-78845-4
eBook Packages: Humanities, Social Sciences and LawLaw and Criminology (R0)